IDIOPATHIC HYPERSOMNIA
Clinical trials for IDIOPATHIC HYPERSOMNIA explained in plain language.
Never miss a new study
Get alerted when new IDIOPATHIC HYPERSOMNIA trials appear
Sign up with your email to follow new studies for IDIOPATHIC HYPERSOMNIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill shows promise for keeping sleep disorders in check over the long haul
Disease control Recruiting nowThis study looks at the long-term safety and how well ALKS 2680 works for people with narcolepsy type 1, type 2, or idiopathic hypersomnia. About 256 adults who finished a previous ALKS 2680 study will take the tablet and be monitored for side effects and improvements in daytime …
Matched conditions: IDIOPATHIC HYPERSOMNIA
Phase: PHASE2, PHASE3 • Sponsor: Alkermes, Inc. • Aim: Disease control
Last updated May 17, 2026 08:55 UTC
-
New pill aims to wake up the chronically sleepy
Symptom relief Recruiting nowThis study tests a new drug, ALKS 2680, to see if it safely reduces excessive daytime sleepiness in people with idiopathic hypersomnia, a condition causing severe sleepiness without clear cause. About 96 adults will take either the drug or a placebo for 8 weeks. The main goal is …
Matched conditions: IDIOPATHIC HYPERSOMNIA
Phase: PHASE2 • Sponsor: Alkermes, Inc. • Aim: Symptom relief
Last updated May 17, 2026 08:52 UTC
-
New orexin mimic aims to wake up sleepy patients
Symptom relief Recruiting nowThis study tests a new drug called ORX750 (cleminorexton) that mimics a natural brain protein (orexin) to help people stay awake. It includes 248 adults with narcolepsy type 1, type 2, or idiopathic hypersomnia. The main goals are to check safety and see if the drug reduces dayti…
Matched conditions: IDIOPATHIC HYPERSOMNIA
Phase: PHASE2 • Sponsor: Centessa Pharmaceuticals (UK) Limited • Aim: Symptom relief
Last updated May 17, 2026 08:46 UTC
-
New drug TAK-360 could help extreme daytime sleepiness
Symptom relief Recruiting nowThis study tests a new medicine called TAK-360 for people with idiopathic hypersomnia (IH), a condition that causes extreme sleepiness even after lots of sleep. The drug works like a brain chemical called orexin that helps keep you awake. Researchers want to see if TAK-360 is saf…
Matched conditions: IDIOPATHIC HYPERSOMNIA
Phase: PHASE2 • Sponsor: Takeda • Aim: Symptom relief
Last updated May 17, 2026 08:45 UTC
-
New hope for chronic sleepiness: experimental drug enters final testing phase
Symptom relief Recruiting nowThis study tests an experimental drug called HBS-301 in 248 adults with idiopathic hypersomnia, a condition causing severe daytime sleepiness, trouble waking up, and fatigue. Participants will receive either the drug or a placebo for several weeks to see if it reduces symptoms. T…
Matched conditions: IDIOPATHIC HYPERSOMNIA
Phase: PHASE3 • Sponsor: Harmony Biosciences Management, Inc. • Aim: Symptom relief
Last updated May 14, 2026 12:03 UTC
-
New sleep drug ORX750 tested for long-term safety in narcolepsy and hypersomnia patients
Symptom relief Recruiting nowThis study looks at the long-term safety and effectiveness of a drug called ORX750 in people with narcolepsy (types 1 and 2) or idiopathic hypersomnia who have already completed a previous ORX750 study. About 90 participants will take the drug and be monitored for side effects an…
Matched conditions: IDIOPATHIC HYPERSOMNIA
Phase: PHASE2 • Sponsor: Centessa Pharmaceuticals (UK) Limited • Aim: Symptom relief
Last updated May 12, 2026 13:43 UTC